Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines.

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Vaccine testing frameworks predate the understanding of
• non-specific effects
• , which influence risks of unrelated diseases.
• Epidemiological data suggest vaccines can alter all-cause mortality/morbidity beyond their intended targets.
• Observed effects vary: live vaccines may decrease mortality/morbidity more than expected, while some non-live vaccines may increase it.

Purpose of the Study:

• To highlight the need for updating vaccine testing and regulatory frameworks.
• To incorporate the assessment of vaccine non-specific effects.
• To propose a new framework for evaluating these effects in clinical trials and post-licensure.

Main Methods:

• Review of epidemiological and immunological studies on vaccine non-specific effects.
• Analysis of current vaccine trial and post-licensure surveillance limitations.
• Development of a proposed framework for incorporating non-specific effect assessment.

Main Results:

• Accumulating evidence indicates vaccines can have significant non-specific effects on health outcomes.
• These effects, potentially mediated by trained immunity and other mechanisms, can be sex-specific (often greater in females).
• Current surveillance often misses these broader impacts, e.g., unrelated infections post-vaccination.

Conclusions:

• The current vaccine regulatory paradigm requires revision to include non-specific effects.
• A new framework is proposed for Phase III trials and post-licensure surveillance to capture these broader immunological impacts.
• Integrating non-specific effects assessment will enhance vaccine safety and efficacy evaluations.